In fact, we recently observed that overexpression of PCDH20 relates to chemosensitivity to cisplatin in HCC cells (unpublished data), suggesting that PCDH20 may represent a potential, useful therapeutic target of HCC. The gene discussed is PCDH20; the disease is hepatocellular carcinoma.